Correlation Between Freeline Therapeutics and Diffusion Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Freeline Therapeutics and Diffusion Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Freeline Therapeutics and Diffusion Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Freeline Therapeutics Holdings and Diffusion Pharmaceuticals, you can compare the effects of market volatilities on Freeline Therapeutics and Diffusion Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Freeline Therapeutics with a short position of Diffusion Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Freeline Therapeutics and Diffusion Pharmaceuticals.

Diversification Opportunities for Freeline Therapeutics and Diffusion Pharmaceuticals

0.09

Correlation Coefficient

Freeline Therapeutics  Diffusion Pharmaceuticals

Significant diversification

The 3 months correlation between Freeline and Diffusion is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Freeline Therapeutics Holdings and Diffusion Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Diffusion Pharmaceuticals and Freeline Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Freeline Therapeutics Holdings are associated (or correlated) with Diffusion Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Diffusion Pharmaceuticals has no effect on the direction of Freeline Therapeutics i.e., Freeline Therapeutics and Diffusion Pharmaceuticals go up and down completely randomly.

Pair Corralation between Freeline Therapeutics and Diffusion Pharmaceuticals

Given the investment horizon of 90 days Freeline Therapeutics Holdings is expected to generate 2.39 times more return on investment than Diffusion Pharmaceuticals. However, Freeline Therapeutics is 2.39 times more volatile than Diffusion Pharmaceuticals. It trades about -0.01 of its potential returns per unit of risk. Diffusion Pharmaceuticals is currently generating about -0.08 per unit of risk. If you would invest  727.00  in Freeline Therapeutics Holdings on September 18, 2024 and sell it today you would lose (296.00) from holding Freeline Therapeutics Holdings or give up 40.72% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Freeline Therapeutics Holdings  vs.  Diffusion Pharmaceuticals

Freeline Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Freeline Therapeutics Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy essential indicators, Freeline Therapeutics is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Diffusion Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Diffusion Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, Diffusion Pharmaceuticals is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Freeline Therapeutics and Diffusion Pharmaceuticals

The main advantage of trading using opposite Freeline Therapeutics and Diffusion Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Freeline Therapeutics position performs unexpectedly, Diffusion Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Diffusion Pharmaceuticals will offset losses from the drop in Diffusion Pharmaceuticals' long position.

The idea behind Freeline Therapeutics Holdings and Diffusion Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.